Skip to main content
NCBI home page
Nature Portfolio logoLink to Nature Portfolio
. 2022 Apr 19;40(6):974. doi: 10.1038/s41587-022-01323-0

Author Correction: Development of spirulina for the manufacture and oral delivery of protein therapeutics

Benjamin W Jester 1, Hui Zhao 1, Mesfin Gewe 1, Thomas Adame 1, Lisa Perruzza 2, David T Bolick 3, Jan Agosti 1, Nhi Khuong 1, Rolf Kuestner 1, Caitlin Gamble 1, Kendra Cruickshank 1, Jeremy Ferrara 1, Rachelle Lim 1, Troy Paddock 1, Colin Brady 1, Stacey Ertel 1, Miaohua Zhang 1, Alex Pollock 1, Jamie Lee 1, Jian Xiong 4,5, Michael Tasch 1, Tracy Saveria 1, David Doughty 1, Jacob Marshall 1, Damian Carrieri 1,6, Lauren Goetsch 1, Jason Dang 1, Nathaniel Sanjaya 1, David Fletcher 1, Anissa Martinez 1, Bryce Kadis 1, Kristjan Sigmar 1, Esha Afreen 1, Tammy Nguyen 1, Amanda Randolph 1, Alexandria Taber 1, Ashley Krzeszowski 1, Brittney Robinett 1, David B Volkin 4, Fabio Grassi 2, Richard Guerrant 3, Ryo Takeuchi 1,7, Brian Finrow 1, Craig Behnke 1, James Roberts 1,✉
PMCID: PMC9200629  PMID: 35440781

Correction to: Nature Biotechnology 10.1038/s41587-022-01249-7, published online 21 March 2022.

In the version of this article initially published, the surname of author Bryce Kadis was misspelled as Kaldis. The name has been corrected in the HTML and PDF versions of the article.

Articles from Nature Biotechnology are provided here courtesy of Nature Publishing Group

RESOURCES